Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuo-How Huang

Showing results (151-160 of 195) with videos related to

Pageof 20
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 7, 2018
Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of AldosteronismKuo-How Huang, Chih-Chin Yu, Ya-Hui Hu, et al.
Journal of Endourology|August 31, 2013
Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: experience from an Asian tertiary referral centerHuai-Ching Tai, Ming-Kuen Lai, Chao-Yuan Huang, et al.
International Journal of Cancer|January 8, 2013
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomesChung-Hsin Chen, Kathleen G Dickman, Chao-Yuan Huang, et al.
Journal of Hypertension|November 26, 2019
Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based studyLeay Kiaw Er, Likwang Chen, Yao-Chou Tsai, et al.
Journal of Clinical Medicine|October 19, 2018
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes MellitusChia-Hui Chang, Ya-Hui Hu, Kuo-How Huang, et al.
Cells|October 20, 2019
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo StudyKuan-Lin Kuo, Shing-Hwa Liu, Wei-Chou Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing AdenomasKang-Yung Peng, Huang-Ming Chang, Yu-Feng Lin, et al.
The World Journal of Men'S Health|October 19, 2023
Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive FactorsJian-Hua Hong, Ming-Chieh Kuo, Yung-Ting Cheng, et al.
Biomedicines|October 26, 2024
Prognostic Outcomes and Predictive Factors in Non-Metastatic Castration-Resistant Prostate Cancer Patients Not Treated with Second-Generation AntiandrogensYu-Jen Wang, Chi-Shin Tseng, Chao-Yuan Huang, et al.
World Journal of Urology|December 13, 2018
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral centerChi-Shin Tseng, Ting-En Tai, Chung-Hung Hong, et al.
Pageof 20

Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 7, 2018
Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of AldosteronismKuo-How Huang, Chih-Chin Yu, Ya-Hui Hu, et al.
Journal of Endourology|August 31, 2013
Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: experience from an Asian tertiary referral centerHuai-Ching Tai, Ming-Kuen Lai, Chao-Yuan Huang, et al.
International Journal of Cancer|January 8, 2013
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomesChung-Hsin Chen, Kathleen G Dickman, Chao-Yuan Huang, et al.
Journal of Hypertension|November 26, 2019
Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based studyLeay Kiaw Er, Likwang Chen, Yao-Chou Tsai, et al.
Journal of Clinical Medicine|October 19, 2018
Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes MellitusChia-Hui Chang, Ya-Hui Hu, Kuo-How Huang, et al.
Cells|October 20, 2019
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo StudyKuan-Lin Kuo, Shing-Hwa Liu, Wei-Chou Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing AdenomasKang-Yung Peng, Huang-Ming Chang, Yu-Feng Lin, et al.
The World Journal of Men'S Health|October 19, 2023
Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive FactorsJian-Hua Hong, Ming-Chieh Kuo, Yung-Ting Cheng, et al.
Biomedicines|October 26, 2024
Prognostic Outcomes and Predictive Factors in Non-Metastatic Castration-Resistant Prostate Cancer Patients Not Treated with Second-Generation AntiandrogensYu-Jen Wang, Chi-Shin Tseng, Chao-Yuan Huang, et al.
World Journal of Urology|December 13, 2018
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral centerChi-Shin Tseng, Ting-En Tai, Chung-Hung Hong, et al.
Pageof 20